Consent for operating an implant is not consent for training

Consent to let biosensor signals operate an implant should not automatically include permission to reuse those signals for future personalization models. Real-time control is necessary for the device; model training is a separate purpose with a different beneficiary and risk profile.

Even if data is anonymized, repeated high-dimensional neural or physiological patterns and derived features may remain linkable over time. The evidence for direct re-identification of implanted BCI datasets is still limited, but that uncertainty is not a reason to make secondary use invisible. At the same time, refusing reuse might make a device less accurate, more expensive, or less accessible—possible tradeoffs, not established outcomes.

Should users approve specific training purposes, inspect which signals contributed to a model, and revoke secondary-use permission without losing core functionality? Challenge this consent model, or explain how you would design the controls.

The distinction is sound, but I would avoid promising inspection at the raw-signal level. A useful control might show categories, time ranges, derived features, and model versions instead. The review’s point about membership inference is more defensible than claiming anyone can simply identify a person from an implant dataset.

“Revoke” needs a defined scope. Deleting source rows is not the same as removing their influence from a trained model, backups, exported checkpoints, and downstream models. Model lineage and unlearning need to be designed before consent becomes a button that only changes the dashboard.

Most users will not approve twelve narrowly worded training purposes. They will tap through, then feel betrayed later. I’d offer a small number of understandable choices, with a genuinely usable default path that preserves operation without making the privacy-preserving option punitive.

I’d treat “anonymized” as a property to test, not a promise to repeat. The threat model includes linkage across sessions, insider access, and someone learning that a person’s data was in a model. Consent cannot compensate for retaining everything forever.

There is a danger of making the ideal control set so elaborate that only well-resourced users can navigate it. If refusing secondary use reduces access in practice, the ethical answer may involve funding or procurement rules—not pretending every individual can negotiate the system alone.

The lineage view should answer ordinary questions: “Did yesterday’s session affect this update?” and “What changes if I withdraw?” If the answer requires reading a model card or understanding embeddings, that is technically transparent but socially opaque.

A strong baseline would be local personalization where feasible, with explicit export for anything leaving the device. It will not solve every model-training problem, but it changes the default from “trust the repository” to “share only for a stated reason.”

For hospitals and buyers, revocation and lineage are governance requirements only if they are auditable. I’d want records showing the consent state at collection, the model versions affected, and what deletion or unlearning actually completed. Otherwise procurement will accept a checkbox as evidence.

If core operation depends on perpetual data surrender, call that part of the product requirement, not consent. A separate opt-in is still worthwhile, but the non-training path has to be funded and maintained or it is consent theater.